Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Leader In Air Purification, Molekule, Launches In Europe To Deliver Clean Indoor Air To Everyone, Everywhere

This image opens in the lightbox

News provided by

Molekule

23 Nov, 2021, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

Molekule is bringing its Air Mini+ and Air Pro air purifiers, powered by patented PECO technology, to the UK and Europe for the first time

LONDON, Nov. 23, 2021 /PRNewswire/ -- Molekule, the science company that reinvented air purification with its groundbreaking PECO technology, today announced that its award-winning air purifiers will be available to consumers in the United Kingdom and across Europe directly via Molekule's website. Molekule's mission is to destroy indoor air pollution and provide crisp, clean indoor air in homes, businesses, and beyond. Starting today, Molekule's best selling air purifiers, Air Mini+ and Air Pro, will be available for purchase throughout the region.

Continue Reading
This image opens in the lightbox
Molekule Air Mini+
This image opens in the lightbox
Molekule Air Pro
This image opens in the lightbox
Molekule Air Pro
This image opens in the lightbox
Molekule Air Mini+

Molekule was founded in 2014 after 25 years of research and development resulted in its innovative PECO technology, which sits at the core of each and every Molekule purifier. Using PECO, Molekule's air purifiers not only collect, but also destroy the widest range of tiny pollutants when compared to traditional air purifier technology; breaking down pollutants at molecular levels such as allergens, mould, bacteria, viruses, and volatile organic compounds (VOCs). Recent research from third party laboratories show that Molekule destroys COVID-19 virus by over 99% in 1 hour in small chamber and swatch lab tests[1], and inactivates H1N1 flu virus by up to 99.99% in single pass experiments[2]. Air Mini+ and Air Pro are both cleared by the U.S. FDA for the destruction of bacteria and viruses, and Air Pro is additionally cleared for the destruction of mould.[3]

Many consumers are well aware of the dangers of outdoor air pollution, specifically in metro areas across Europe. According to the European Environment Agency, around 90% of people living in European cities are exposed to pollutant concentrations that are higher than what is deemed harmful to health.[4] What many consumers aren't aware of is that indoor air can be just as polluted, sometimes even more polluted, than the air we breathe outdoors.[5] Molekule was founded specifically to help address indoor air pollution, giving people more control over the air they breathe in their daily lives.

Jonathan Harris, CEO at Molekule comments: "The air we breathe day in and day out is critical to our overall well-being. Our air purifiers are able to destroy pollutants at microscopic levels – chemicals and particles that we aren't even able to see – and leave behind cleaner, safer indoor air. We've had our sights set on Europe for a long time and our team cannot wait to introduce European customers to the power of PECO technology."

As a science-based company, Molekule conducts extensive testing of its technology internally as well as with certified third-party laboratories. PECO technology has been independently tested at the Intertek testing laboratory, independent third-party testing laboratory ARE, University of Minnesota and with one of the world's foremost research laboratories for indoor air quality, Lawrence Berkeley National Laboratory (Berkeley).

Alongside its revolutionary approach to air purification, Molekule's human-centered and contemporary design ensures that its products are both beautiful and easy to use. The physical design is thoughtful in form, material, size and footprint, and its product design considerations are expressed down to the finest detail. Consumers can control their Air Mini+ and Air Pro purifiers and receive status updates on their air purifier's filters via the Molekule app, on iOS and Android.

Headquartered in the US, Molekule now sells internationally in the UK and Europe as well as Canada, India, Japan and Korea, bringing its unique air purification process to a global market. In the UK and Europe, Molekule is launching its Air Pro and Air Mini+ purifiers. 

About Molekule 

Molekule is on a mission to provide clean indoor air to everyone, everywhere. Molekule was born from the critical need to leverage science and innovation to address the adverse impacts of polluted indoor air. Based on 25 years of research and development, the company's patented PECO technology destroys the widest range of pollutants, including VOCs, mould, bacteria, viruses, and allergens, when compared to conventional filters. Molekule's range of air purification solutions have been reviewed and validated by third-party laboratories, as well as continual internal testing, and its medical-grade products have been granted medical device clearance by the U.S. FDA. Molekule is headquartered in the US and sells internationally in the UK, EU, Canada, India, Japan, and South Korea, bringing its unique air purification process to a global customer base. 

For more information, please visit https://molekule.uk/ or https://molekule.eu/

Key Products

Air Mini+ 
The Air Mini+ is built for rooms up to 23m2 (250 sq. ft.). Air Mini+ is an ideal choice for apartment rooms, bedrooms, and home offices. It can capture not only fine dust but also destroy a wide range of indoor pollutants such as VOCs, bacteria, viruses, mould and allergens. A particle sensor enables the purifier to sense particles in the air and if on Auto Protect Mode, it will automatically adjust the fan speed accordingly. Air Mini+ is also Apple HomeKit-enabled, so users can control it using the Home app on their iPad or iPhone. 

UK
RRP: £449 inc VAT 

EU
RRP: €499 inc VAT 

Air Pro   
Air Pro is Molekule's most advanced purifier, designed to destroy pollutants such as VOCs, bacteria, viruses, mould and allergens in extra-large spaces that are up to 93m2 (1000 sq. ft.). There are two Auto Protect Modes that auto-adjust the airflow for particle protection at noise levels (Standard and Quiet). Users can use the touchscreen or the app to swipe and tap in order to see the device info, filter status, or air particle levels.

UK 
RRP: £1049 inc VAT 

EU
RRP: €1199 inc VAT 

[1] 2021 test results demonstrate PECO air purification technology's success in removing 99.98% of the COVID-19 virus SARS-CoV-2 from the air, and achieving total destruction rates exceeding 99% after one hour. These results are from a multiple pass chamber test and swatch level test, respectively. The multiple pass chamber test utilized an Air Mini device in a small 5.3 cubic-foot chamber with a single injection of aerosolized virus, and the swatch level test used Molekule's proprietary PECO-Filter media for direct virus application. Testing conducted at the University of Nebraska Medical Center, Department of Pharmacology & Experimental Neuroscience. No air purifier can prevent transmission of a virus and air purifiers are not a substitute for ventilation. Molekule recommends use of ventilation, PPE & social distancing and following directions of SAGE & other gov't authorities.  Actual results will depend on the environment and in-room location that the air purifier is placed in and real-world results may be less than those observed in the laboratory tests.

[2] In 2020, the University of Minnesota College of Science and Engineering and College of Veterinary Medicine tested Molekule's PECO technology using an Air Mini purifier and its operating flow rate in single-pass efficiency testing with viable viruses in aerosol transmission. Methods developed for the research allowed measurement and characterization of airborne virus detection and inactivation by air purification technologies. For the PECO technology, testing showed near 99.9% removal and total removal rates (virus titer based) approaching 99.99% for influenza A after four hours. Dr. Chris Hogan and Dr. Montserrat Torremorell led this research.

[3] Although the U.S. FDA clearances do not apply specifically to SARS-CoV-2, Molekule's devices satisfy the criteria established in the U.S. FDA's non-enforcement guidance for air purifier use in connection with SARS-CoV-2 during the pandemic.  Molekule devices are not intended for medical use in the United Kingdom or Europe and have not been cleared as medical devices in those countries.

[4] "Air Pollution." European Environment Agency, 23 Nov. 2020, https://www.eea.europa.eu/themes/air/intro.

[5] U.S. Environmental Protection Agency. 1987. The total exposure assessment methodology (TEAM) study: Summary and analysis. EPA/600/6-87/002a. Washington, DC.

Photo - https://mma.prnewswire.com/media/1693424/Molekule_Air_Mini.jpg
Photo - https://mma.prnewswire.com/media/1693425/Molekule_Air_Pro.jpg
Photo - https://mma.prnewswire.com/media/1693426/Molekule_Air_Pro.jpg
Photo - https://mma.prnewswire.com/media/1693427/Molekule.jpg
Logo - https://mma.prnewswire.com/media/1693428/Molekule_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.